High-Risk Coronary Plaque at Coronary CT Angiography Is Associated with Nonalcoholic Fatty Liver Disease, Independent of Coronary Plaque and Stenosis Burden: Results from the ROMICAT II Trial-Reference-Cited by-同舟云学术

High-Risk Coronary Plaque at Coronary CT Angiography Is Associated with Nonalcoholic Fatty Liver Disease, Independent of Coronary Plaque and Stenosis Burden: Results from the ROMICAT II Trial

Published:2015-03 Issue:3 Volume:274 Page:693-701
ISSN:0033-8419
Container-title:Radiology
language:en
Short-container-title:Radiology

Author:

Puchner Stefan B.,Lu Michael T.,Mayrhofer Thomas,Liu Ting,Pursnani Amit,Ghoshhajra Brian B.,Truong Quynh A.,Wiviott Stephen D.,Fleg Jerome L.,Hoffmann Udo,Ferencik Maros

Publisher

Radiological Society of North America (RSNA)

Subject

Radiology, Nuclear Medicine and imaging

Link

http://pubs.rsna.org/doi/pdf/10.1148/radiol.14140933

Reference35 articles.

1. Prevalence of hepatic steatosis in an urban population in the United States: Impact of ethnicity

2. Nonalcoholic fatty liver disease: An agenda for clinical research

3. Metabolic and Adipokine Profile of Chinese Patients With Nonalcoholic Fatty Liver Disease

4. Determinants of the association of overweight with elevated serum alanine aminotransferase activity in the United States

5. Nonalcoholic steatohepatitis, insulin resistance, and metabolic syndrome: Further evidence for an etiologic association

Cited by 117 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Hepatic Steatosis and High-Risk Coronary Plaque;JACC: Cardiovascular Imaging;2024-08

2. Application and research progress of magnetic resonance proton density fat fraction in metabolic dysfunction-associated steatotic liver disease: a comprehensive review;Abdominal Radiology;2024-07-24

3. Lipoprotein subclasses are associated with Hepatic steatosis: insights from the prospective multicenter imaging study for the evaluation of chest pain (PROMISE) clinical trial;American Journal of Preventive Cardiology;2024-06

4. Managing chronic coronary syndrome: how do we achieve optimal patient outcomes?;Expert Review of Cardiovascular Therapy;2024-05-20

5. Increased prevalence of high‐risk coronary plaques in metabolic dysfunction associated steatotic liver disease patients: A meta‐analysis;European Journal of Clinical Investigation;2024-02-23